Data / Form D filings / CHRONIX BIOMEDICAL INC
CHRONIX BIOMEDICAL INC: Form D filings
CHRONIX BIOMEDICAL INC, a biotechnology company in San Jose, CA, filed 9 Form D notices with the SEC between 2009 and 2017. The latest, on July 18, 2017, reports $3.3 million sold of a $8 million offering to 40 investors.
Find out what CHRONIX BIOMEDICAL INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5941 OPTICAL COURT, SUITE 203E, San Jose, CA, 95138
- Phone
- (408) 960-2307
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1129116
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 18, 2017 | New notice | $8,000,000 | $3,306,954 | $4,693,046 | 40 | Jun 30, 2017 | sec.gov |
| May 18, 2017 | New notice | $1,999,999 | $1,471,041 | $528,958 | 25 | Dec 9, 2016 | sec.gov |
| Oct 31, 2016 | New notice | $5,012,802 | $5,012,802 | $0 | 25 | Jun 4, 2015 | sec.gov |
| Apr 9, 2014 | Amendment | $14,500,000 | $3,429,767 | $11,070,233 | 26 | Dec 27, 2012 | sec.gov |
| Apr 8, 2014 | New notice | $14,500,000 | $3,429,767 | $11,070,233 | 26 | Jul 1, 2013 | sec.gov |
| Oct 31, 2012 | New notice | $2,000,000 | $1,415,000 | $585,000 | 7 | Aug 27, 2012 | sec.gov |
| Mar 11, 2011 | New notice | $3,000,000 | $2,781,800 | $218,200 | 11 | Jan 31, 2011 | sec.gov |
| Sep 15, 2010 | New notice | $2,000,000 | $1,741,389 | $258,611 | 14 | Mar 10, 2010 | sec.gov |
| Nov 3, 2009 | New notice | $1,700,000 | $1,487,140 | $212,860 | 14 | Sep 11, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William B Mitchell | Director | |
| Michael B Jerstad | Director | |
| William B Boeger III | Director | |
| David B MacKenzie | Director | |
| Ekkehard B Schuetz | Executive Officer | |
| Robert B Leppo | Director | |
| John DiPietro | Executive Officer | |
| Howard B Urnovitz | Executive Officer, Director | |
| Paul B Freiman | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Jul 17, 2017 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CHRONIX BIOMEDICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.